Karen Walker - Jun 6, 2024 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Chief Technology Officer
Signature
By: /s/ Karen Walker
Stock symbol
KYTX
Transactions as of
Jun 6, 2024
Transactions value $
$42,591
Form type
4
Date filed
6/10/2024, 06:56 PM
Previous filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYTX Common Stock Options Exercise $42.6K +9.64K $4.42* 9.64K Jun 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYTX Stock Option (Right to Buy) Options Exercise $0 -9.64K -10.44% $0.00 82.6K Jun 6, 2024 Common Stock 9.64K $4.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter.